Literature DB >> 24986419

GRACE score predicts heart failure admission following acute coronary syndrome.

David A McAllister1, Nynke Halbesma2, Kathryn Carruthers3, Martin Denvir3, Keith A Fox3.   

Abstract

BACKGROUND: Congestive heart failure (CHF) is a common and preventable complication of acute coronary syndrome (ACS). Nevertheless, ACS risk scores have not been shown to predict CHF risk. We investigated whether the at-discharge Global Registry of Acute Coronary Events (GRACE) score predicts heart failure admission following ACS. METHODS AND
RESULTS: Five-year mortality and hospitalization data were obtained for patients admitted with ACS from June 1999 to September 2009 to a single centre of the GRACE registry. CHF was defined as any admission assigned WHO International Classification of Diseases 10 diagnostic code I50. The hazard ratio (HR) for CHF according to GRACE score was estimated in Cox models adjusting for age, gender and the presence of CHF on index admission. Among 1,956 patients, CHF was recorded on index admission in 141 patients (7%), and 243 (12%) were admitted with CHF over 3.8 median years of follow-up. Compared to the lowest quintile, patients in the highest GRACE score quintile had more CHF admissions (116 vs 17) and a shorter time to first admission (1.2 vs 2.0 years, HR 9.87, 95% CI 5.93-16.43). Per standard deviation increment in GRACE score, the instantaneous risk was more than two-fold higher (HR 2.28; 95% CI 2.02-2.57), including after adjustment for CHF on index admission, age and gender (HR 2.49; 95% CI 2.06-3.02). The C-statistic for CHF admission at 1-year was 0.74 (95% CI 0.70-0.79).
CONCLUSIONS: The GRACE score predicts CHF admission, and may therefore be used to target ACS patients at high risk of CHF with clinical monitoring and therapies. © The European Society of Cardiology 2014.

Entities:  

Keywords:  Heart failure; myocardial infarction; prognosis

Mesh:

Year:  2014        PMID: 24986419     DOI: 10.1177/2048872614542724

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN: 2048-8726


  5 in total

1.  For Primary Prevention, Should All Moderate- to High-Risk Patients Be Considered Candidates for Acetylsalicylic Acid?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2020-02-01

2.  Novel multi-marker proteomics in phenotypically matched patients with ST-segment myocardial infarction: association with clinical outcomes.

Authors:  Jay S Shavadia; Wendimagegn Alemayehu; Christopher deFilippi; Cynthia M Westerhout; Jasper Tromp; Christopher B Granger; Paul W Armstrong; Sean van Diepen
Journal:  J Thromb Thrombolysis       Date:  2021-10-27       Impact factor: 2.300

Review 3.  Heart failure after myocardial infarction in the era of primary percutaneous coronary intervention: Mechanisms, incidence and identification of patients at risk.

Authors:  Thomas J Cahill; Rajesh K Kharbanda
Journal:  World J Cardiol       Date:  2017-05-26

4.  Risk evaluation of new-onset atrial fibrillation complicating ST-segment elevation myocardial infarction: a comparison between GRACE and CHA2DS2-VASc scores.

Authors:  Jiachen Luo; Liming Dai; Jianming Li; Jinlong Zhao; Zhiqiang Li; Xiaoming Qin; Hongqiang Li; Baoxin Liu; Yidong Wei
Journal:  Clin Interv Aging       Date:  2018-06-06       Impact factor: 4.458

5.  Phase 2 Randomised Controlled Trial and Feasibility Study of Future Care Planning in Patients with Advanced Heart Disease.

Authors:  Martin A Denvir; Sarah Cudmore; Gill Highet; Shirley Robertson; Lisa Donald; Jacqueline Stephen; Kristin Haga; Karen Hogg; Christopher J Weir; Scott A Murray; Kirsty Boyd
Journal:  Sci Rep       Date:  2016-04-19       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.